All In Biotech

Drug Trial Radar · NCT05084638

Study to Assess the Effect of Ofatumumab in Treatment Naïve, Very Early RRMS Patients Benchmarked Against Healthy Controls.

AGNOS: An 18-month, Open-label, Multi-Center Phase IV Study to Assess the Effect of Ofatumumab 20mg SC Monthly in Treatment Naïve, Very Early Relapsing Remitting Multiple Sclerosis Patients Benchmarked Against Healthy Controls on Select Outcomes.

Last checked: Nov 20, 2026Latest source record: Feb 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

180

Actual

Start

Jan 25, 2022

Primary completion

Feb 4, 2025

Study completion Feb 11, 2026

Sponsor

Lead sponsor
Novartis PharmaceuticalsNovartis (NVS)
Sponsor type
Industry
First posted
Oct 20, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 35 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study evaluates the impact of ofatumumab in Relapsing Remitting Multiple Sclerosis (RRMS) participants that are very early in the course of their disease using clinical and magnetic resonance imaging (MRI) outcomes. The study also assesses changes in disease using monitoring techniques including digital biometric device use, biomarker analysis and non-conventional MRI. Select outcomes in the ofatumumab treated group will be compared to a group of Healthy participants to determine if there are similarities between the groups after the patients with MS undergo treatment with ofatumumab.

Conditions

  • Relapse Remitting Multiple Sclerosis

Interventions

  • OfatumumabDrug

    20mg subcutaneous injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Achieving NEDA-3 (No Evidence of Disease Activity-3)Time frame: Month 6 to month 18

Locations

36 sites in 2 countries. Site status is shown where the registry gives one.

  • MD First Research

    Chandler, Arizona

  • Barrow Neurological Clinics at St Josephs Hospital and MC

    Phoenix, Arizona

  • Arizona Neuroscience Research LLC

    Phoenix, Arizona

  • Keck School of Medicine

    Los Angeles, California

  • Lundquist Inst BioMed at Harbor

    Torrance, California

  • Regina Berkovich MD PhD Inc

    West Hollywood, California

  • UC Health Neuroscience Ctr

    Aurora, Colorado

  • MedStar Health

    Washington D.C., District of Columbia

  • Neurology of Central FL Res Ctr

    Altamonte Springs, Florida

  • First Choice Neurology

    Boca Raton, Florida

  • University of Florida

    Gainesville, Florida

  • Neurology Associates PA

    Maitland, Florida

  • Orlando Health Clinical Trials

    Orlando, Florida

  • Emerald Coast Neurology

    Pensacola, Florida

  • Tallahassee Neurological Clinic

    Tallahassee, Florida

  • University Of South Florida

    Tampa, Florida

  • Shepherd Center

    Atlanta, Georgia

  • Ochsner Cancer Institute

    New Orleans, Louisiana

  • University of Massachusetts Medical School

    Worcester, Massachusetts

  • Henry Ford Hospital

    Detroit, Michigan

  • Renown Institute for Neurosciences

    Reno, Nevada

  • Neuroscience Institute at Hackensack

    Hackensack, New Jersey

  • University of New Mexico

    Albuquerque, New Mexico

  • Velocity Clinical Research

    Raleigh, North Carolina

  • Neurology Diagnostics Inc

    Dayton, Ohio

  • Multiple Sclerosis Center of Excellence of OMRF

    Oklahoma City, Oklahoma

  • Thomas Jefferson University Hospital

    Philadelphia, Pennsylvania

  • Sibyl Wray MD Neurology PC

    Knoxville, Tennessee

  • Univ of Texas Southwest Med Center

    Dallas, Texas

  • UT Health Science Center

    Houston, Texas

  • Lonestar Neurology of San Antonio

    San Antonio, Texas

  • Evergreen Health Multiple Sclerosis Center

    Kirkland, Washington

  • MultiCare Neuroscience Center of Washington

    Tacoma, Washington

  • West Virginia University Hospital

    Morgantown, West Virginia

  • Medical College of Wisconsin

    Milwaukee, Wisconsin

  • Caribbean Center for Clinical Research, Inc

    Guaynabo, Puerto Rico

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.